Loading...

Elanco Animal Health Inc

5EA.DEXETRA
HealthcareMedical - Pharmaceuticals
19.20
0.00(0.00%)

Elanco Animal Health Inc (5EA.DE) Company Profile & Overview

Explore Elanco Animal Health Inc’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Elanco Animal Health Inc (5EA.DE) Company Profile & Overview

Elanco Animal Health, Inc. engages in the innovation, development, manufacture and market products for companion and food animals. The company is headquartered in Greenfield, Indiana and currently employs 5,590 full-time employees. The firm offers its products under four primary categories, such as Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The company provides a range of parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The company also offers a pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The company also provides treatments for otitis (ear infections), as well as cardiovascular and dermatology indications. Its portfolio in Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics. The company also provides products in poultry and aquaculture production.

SectorHealthcare
IndustryMedical - Pharmaceuticals
CEOMr. Jeffrey Simmons

Contact Information

18773526261
2500 Innovation Way N, Greenfield, IN

Company Facts

5,760 Employees
IPO DateSep 20, 2018
CountryUS

Frequently Asked Questions